Experimental model of pulmonary metastasis treatment with IFNα

Cancer Letters

Volumn 225, Issue 1, 2005, Pages 75-83

  Martínez, Cristina ^a   Vicente, Vicente ^a   Yáñez, Ma Josefa ^a   García, Juana Ma ^a   Canteras, Manuel ^a   Alcaraz, Miguel ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

B16F10 melanoma; Interferon alpha; Pulmonary metastasis

Indexed keywords

ALPHA INTERFERON; ALPHA2A INTERFERON; RECOMBINANT ALPHA2A INTERFERON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CALCULATION; CANCER INVASION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; FEMALE; HISTOLOGY; IMAGE ANALYSIS; IMPLANTATION; INOCULATION; LUNG METASTASIS; MELANOCYTE; MICROSCOPY; MOUSE; NONHUMAN; PARAMETER; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INTERFERON-ALPHA; LUNG NEOPLASMS; MELANOCYTES; MELANOMA; MICE; NEOPLASMS, EXPERIMENTAL; SKIN NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS;

EID: 19544392132     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.11.047     Document Type: Article

References (40)

1. D. Serraino, L. Frattino, W. Ginni, C. Campisi, M. Pietropaolo, G. Trimarco, and V. Marigliano Epidemiological aspects of cutaneous malignant melanoma (review) Oncol. Rep. 5 1998 905 909
2. M.S. Linet Evolution of cancer epidemiology Epidemiol. Rev. 22 2000 35 56
3. R.T. Greenlee, M.B. Hill-Harmon, T. Murray, and M. Thun Cancer statistics CA Cancer J. Clin. 51 2001 15 36
4. D.H. Harpole Jr, C.M. Johnson, W.G. Wolfe, S.L. George, and H.F. Seigler Analysis of 945 cases of pulmonary metastatic melanoma Thorac. Cardio. Surg. 103 1992 743 750
5. J. Majeski Bilateral breast masses as initial presentation of widely metastatic melanoma J. Surg. Oncol. 72 1999 175 177
6. I.J. Fidler Critical determinants of metastasis Semin. Cancer Biol. 12 2002 89 96
7. S.J. Frank, and M. Meyers Interferon as adjuvant therapy for high risk melanoma Melanoma Lett. 13 1995 1 4
8. P. Mohr, M. Wechenthal, and A. Hauschild Adjuvant therapy in melanoma Onkologie 26 2003 227 233
9. S.S. Legha The role of interferon alfa in the treatment of metastatatic melanoma Semin. Oncol. 24 1997 S24 S31
10. J.M. Richards Sequential chemoimmunotherapy for metastatic melanoma Semin. Oncol. 18 1991 91 95
11. A. Håkansson, B. Gustafsson, L. Krysander, B. Hjelmqvist, and B. Rettrup On down-regulation of the immune response to metastatic malignant melanoma Cancer Inmunol. Inmunother. 48 1999 253 262
12. A. Lentini, F. Autuoria, P. Mattiolia, M. Caragliab, A. Abbruzzeseb, and S. Beninati Evaluation of the efficacy of potential antineoplastic drugs on tumour metastasis by a computer-assisted image analysis Eur. J. Cancer 36 2000 1572 1577
13. K.M. Miner, T. Kawaguchi, G.W. Uba, and G.L. Nicolson Clonal drift of cell surface, melanogenic and experimental metastatic properties of in vivo-selected brain meninges-colonizing murine B16 melanoma Cancer Res. 4 1982 4631 4638
14. K.W. Brunos, and G.L. Nicolson Selection of malignant melanoma variant cell lines for ovary colonization J. Supramol. Struct. 11 1979 517 528
15. T.W. Tao, M.M. Burger, A. Matter, and K. Vogel Liver-colonizing melanoma cells selected from B-16 melanoma Int. J. Cancer 23 1979 854 857
16. L. Gath, G.L. Nicolson, and K. Dulski Organ specificity of metastatic tumor colonization is related to organ-selective growth properties of malignant cells Int. J. Cancer 38 1986 289 294
17. S. Kakuta, Y. Tagawa, S. Shibata, M. Nanno, and Y. Iwakura Inhibition of B16 melanoma experimental metastasis by interferon-γ through direct inhibition of cell proliferation and activation of antitumor host mechanisms Inmunology 105 2002 92 100
18. H. Kikkawa, H. Imafuku, H. Tsukada, and N. Oku Possible of immune surveillance at the initial phase of metastasis produced by B16BL6 melanoma cells Febs Lett. 467 2002 11 216
19. V. Vicente, C. Martínez, J. Yáñez, M. Alcaraz, and M. Canteras Melanoma metastásico pulmonar: efectos del etanol y de flavonoides Rev. Esp. Patol. 36 2003 425 432
20. J. Nakayama, A. Urabe, K. Toyofuku, S. Taniguchi, and Y. Hori Suppression of murine melanoma growth with a combination of micowave hyperthermia and local injection of interleukin 2 Bri. J. Dermatol. 130 1994 717 724
21. W. Zhang, Y. Wang, and Y. Hou Effects of Chinese medical fungus water extract on tumor metastasis and some parameters of immune function Int. Inmunopharmacol. 4 2004 461 468
22. M. Kobayashi, H. Kobayashi, R.B. Pollard, and F. Suzuki A pathogenic role of th2 cells and their cytokine products on pulmonary metastasis of murine B16 Melanoma J. Immunol. 160 1998 5869 5873
23. K. Hellstrand, A. Asea, and S. Hermodsson Role of histamine in natural killer cells-mediated resistance against tumor cells J. Immunol. 145 1990 4365 4370
24. A.M.M. Eggermont, and M. Gore European approach to adjuvant therapy of intermediate and high-risk malignant melanoma Sem. Oncol. 29 2002 382 388
25. M.S. Sabel, and V.K. Sondak Pros and Cons of adjuvant Interferon in the treatment of melanoma Oncologist 8 2003 451 458
26. J. Hansson Systemic therapy of malignant melanoma Med. Oncol. 14 1997 73 81
27. A.K. Bossserhoff, B. Echtenacher, R. Hein, and R. Buettner Functional role of melanoma inhibitory activity in regulating invasion and metastasis of malignant melanoma cells in vivo Melanoma Res. 11 2001 417 421
28. H.T. Fuzii, and L.R. Travassos Transiente resistance to B16F10 melanoma growth and metastasis in CD43 -/-mice Melanoma Res. 12 2002 9 16
29. A. Lentini, H.K. Kleinman, V. Mattioli, V. Autuori-Pezzoli, L. Nicolini, and A. Pietrini Inhibition of melanoma pulmonary metastasis by methylxanthines due to decreased invasión and proliferation Melanoma Res. 8 1998 131 137
30. H. Gutman, J. Schachter, E. Stopel, R. Gutman, and J. Lahav Impaired platelet aggregation in melanoma patients treated with interferon-alpha-2b adjuvant therapy Cancer 94 2002 780 785
31. H. Engelberg Actions of heparin that may affect the malignant process Cancer 85 1999 257 272
32. B. Nieswandt, M. Hafner, B. Echtrncher, and D.N. Mannel Lysis of tumor cells by natural killer cells in mice is impeded by platelets Cancer 59 1999 1295 1300
33. M.L. Nierodzik, A. Kelpfish, and S. Karpatkin Role of platelets, thrombim, integrin IIb-IIIa, fibronectin and von Willebrand factor on tumor adhesion in vitro and metastasis in vivo Throm. Haemost. 74 1995 282 290
34. S. Tedejarati, C.H. Baker, S. Apte, S. Huang, J.K. Wolf, J.J. Killion, and I.J. Fólder Synergistic therapy of human ovarian carcinoma implanted orthotopically in nude mice by optimal biological dose of pegylated interferon α combined with paclitaxel Clin. Cancer Res. 8 2002 2413 2422
35. O. Sangfelt, S. Erickson, and D. Grander Mechanisms of interferon-induced cell cycle arrest Front. Biosci. 5 2000 D479 D487
36. E. Maellaro, L. Pacenti, and B. Del Bello Different effects of interferon-alpha on melanoma cell lines: a study on telomerase reverse transcriptase, telomerase activity and apoptosis Br. J. Dermatol. 148 2003 1115 1124
37. D. Grebenova, K. Kuzelova, O. Fuchs, P. Halada, V. Havlicek, I. Marinov, and Z. Hrkal Interferon-alpha suppresses proliferation of chronic myelogenous leukemia cells K562 by extending cell cycle S-phase without inducing apoptosis Blood Cells Mol. Dis. 32 2004 262 269
38. A. Håkansson, B. Gustafsson, L. Krysander, and L. Håkansson Tumour-infiltrating lymphocytes in metastatic malignant melanoma and response to interferon alpha treatment Br. J. Cancer 74 1996 670 676
39. A. Håkansson, B. Gustafsson, L. Krysander, and L. Håkansson Effect of IFN-alpha on tumor-infiltrating mononuclear cells and regressive changes in metastatic malignant melanoma J. Interferon Cytokine Res. 18 1998 33 39
40. L. Wang, W.Z. Wu, H.C. Sun, X.F. Wu, L.X. Qin, and Y.K. Liu Mechanism of Interferon alfha on inhibition of Metastasis and Angiogenesis of hepatocellular Carcinoma after curative resection in nude mice J. Gastrointest. Surg. 7 2003 587 594